Network origin in Peter D. Flynn first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 24 | |
| Public Company | Biotechnology | 12 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Peter D. Flynn via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Sales & Marketing General Counsel Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
| NEUROCRINE BIOSCIENCES, INC. | Pharmaceuticals: Major | Director of Finance/CFO Chairman Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| SANGAMO THERAPEUTICS, INC. | Biotechnology | General Counsel Investor Relations Contact | |
| ILLUMINA, INC. | Biotechnology | Director/Board Member Chairman Director/Board Member | |
| CHIMERIX, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| PHASEBIO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
ISB Accelerator Corp.
 ISB Accelerator Corp. Miscellaneous Commercial ServicesCommercial Services ISB Accelerator Corp. is involved in the study of biological systems to help identify strategies for predicting and preventing diseases such as cancer, diabetes and AIDS. The company is located in Seattle, WA. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer Director/Board Member | |
PowerVision, Inc.
 PowerVision, Inc. Electronic ComponentsElectronic Technology PowerVision, Inc. develops fluid-controlled intraocular lens. The firm provides FluidVision accommodating intraocular lens technology, which restores the vision of youth to middle aged or elderly individuals affected by presbyopia and cataracts regain to adjust focus for clear vision at all distances. The company was founded by Matthew A. Frinzi, Randy McDonald, and Barry Cheskin in 2002 and is headquartered in Belmont, CA. | Electronic Components | Director/Board Member Chief Executive Officer | |
Ren Pharmaceuticals, Inc.
 Ren Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ren Pharmaceuticals was formed in the fall of 2006 with the aim of bringing together talented and experienced people who are passionate about building a cardio-renal/renal- focused drug development company. Ren Pharmaceuticals closed a Series A financing in November 2006 with Sanderling Ventures, Venrock Associates and Amgen Ventures as investors. The company's R&D is currently located in South San Francisco, California. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| RECEPTOS INC | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member | |
Domain Associates LLC
 Domain Associates LLC Investment ManagersFinance Domain Associates LLC (Domain Associates) is a venture capital firm founded in 1985. The firm is headquartered in Princeton, New Jersey. | Investment Managers | Private Equity Investor Consultant / Advisor | |
| The Trustees of Columbia University in The City of New York | College/University | Graduate Degree Graduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Corporate Officer/Principal | |
| Stanford University | College/University | Doctorate Degree Graduate Degree Undergraduate Degree Graduate Degree | |
| University of California, Los Angeles | College/University | Undergraduate Degree Masters Business Admin | |
| San Diego State University | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools. | College/University | Undergraduate Degree Masters Business Admin | |
| University of California, Irvine | College/University | Corporate Officer/Principal Masters Business Admin | |
| University of California San Diego | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree | |
| University of California, Santa Barbara | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
Ascenta Therapeutics, Inc.
 Ascenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ascenta Therapeutics, Inc. engages in the discovery and development of medicines for cancer. Its core technology consists of agents designed to re-establish the natural program of apoptosis (cell death) in abnormal cancer cells. Its has three small molecule programs against distinct apoptosis targets: Bcl-2 (AT-101 – an oral pan-Bcl2 inhibitor), IAP (AT-406 – an oral multi-IAP inhibitor) and HDM2. The company was founded by Dajun Yang, Marc E. Lippman, and Shaomeng Wang on June 5, 2006 and is headquartered in Malvern, PA. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
National Venture Capital Association
 National Venture Capital Association Miscellaneous Commercial ServicesCommercial Services National Venture Capital Association provides business association services. It facilitates networking opportunities and provides research data to its members. The company is headquartered in Washington, DC. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
Drug Information Association
 Drug Information Association Miscellaneous Commercial ServicesCommercial Services The Drug Information Association is a non-profit multidisciplinary association that operates to promote health and well-being. The non-profit company is based in Horsham, PA. Marwan Fathallah has been the CEO of the company since 2023. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Accelerator Services Corp
 Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Investment Managers | Private Equity Investor Founder Director/Board Member | |
BioVascular, Inc.
 BioVascular, Inc. Pharmaceuticals: MajorHealth Technology BioVascular, Inc. develops drugs and devices for control of intimal hyperplasia associated with vascular procedures. It is a integrated specialty cardiovascular therapeutic company, and to utilize corporate partnerships in markets that have complex marketing barriers and/or combination technologies. The company was founded by John H. Parrish and Paul F. Glidden in 2005 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| UCLA School of Law | College/University | Graduate Degree Graduate Degree | |
| REGULUS THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer President | |
| American Cancer Society New England Division, Inc. | Director/Board Member | ||
| IGNYTA INC | Biotechnology | Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| Boston College Law School | College/University | Graduate Degree Graduate Degree | |
GRAIL LLC
 GRAIL LLC Electronic Equipment/InstrumentsElectronic Technology GRAIL LLC is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA. | Electronic Equipment/Instruments | Chief Executive Officer Director/Board Member | |
| EQUILLIUM, INC. | Biotechnology | Director/Board Member Director of Finance/CFO | |
| LYELL IMMUNOPHARMA, INC. | Biotechnology | General Counsel Director/Board Member | |
Nalpropion Pharmaceuticals, Inc.
 Nalpropion Pharmaceuticals, Inc. Managed Health CareHealth Services Nalpropion Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the treatment of weight loss. Its products include CONTRAVE, analtrexone HCl & bupropion HCl extended release and Mysimba, a naltrexone HCl/ bupropion HCl prolonged release. The company is headquartered in Morristown, NJ. | Managed Health Care | Director of Finance/CFO Compliance Officer | |
Radionetics Oncology, Inc.
 Radionetics Oncology, Inc. Pharmaceuticals: MajorHealth Technology Radionetics Oncology, Inc. is a clinical stage radiopharmaceutical company based in Menlo Park, CA. Radionetics Oncology, Inc. focuses on the discovery and development of novel radiotherapeutics for the treatment of various oncology indications. Radionetics Oncology spun out of Crinetics Pharmaceuticals and is supported by Frazier Life Sciences, 5AM Ventures, DCVC Bio, Crinetics Pharmaceuticals, and GordonMD Investments. The company is advancing a pipeline of small molecule radioligands that target G-protein coupled receptors to treat a wide range of cancers, including adrenocortical carcinoma, breast cancer, and lung cancer. The company's platform technology uses nonpeptide, small molecule targeting to deliver therapeutic radioisotopes selectively to tumors expressing peptide receptors. The company's pipeline consists of multiple lead drug candidates, and they are conducting additional drug discovery efforts in collaboration with Crinetics Pharmaceuticals. The market for radiopharmaceuticals is expected to rise to $12.6 billion by 2027. The company was founded by Scott R. Struthers, and Paul A. Grayson has been the CEO since 2024. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| ATARA BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | General Counsel Director/Board Member | |
| METACRINE, INC. | Biotechnology | Chief Executive Officer Chief Executive Officer |
Statistics
International
| United States | 51 |
Sectoral
| Health Technology | 30 |
| Consumer Services | 13 |
| Commercial Services | 4 |
| Electronic Technology | 3 |
| Finance | 3 |
Operational
| Director/Board Member | 270 |
| Independent Dir/Board Member | 84 |
| Corporate Officer/Principal | 83 |
| Chief Executive Officer | 57 |
| President | 52 |
Most connected contacts
| Insiders | |
|---|---|
| Robert Nelsen | 80 |
| Eckard Weber | 46 |
| Brian H. Dovey | 40 |
| Louis C. Bock | 27 |
| Wendy Dixon | 25 |
| William Rastetter | 24 |
| Paul Grayson | 21 |
| Robert Epstein | 20 |
| Deborah Jorn | 20 |
| Peter Honig | 20 |
| David Endicott | 18 |
| Pratik Multani | 16 |
| Zachary Hornby | 15 |
| Mark Enyedy | 15 |
| Preston Klassen | 15 |
- Stock Market
- Insiders
- Peter D. Flynn
- Company connections
